These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24477666)

  • 1. Improved visual outcome with early treatment in macular edema secondary to retinal vein occlusions: 6-month results of a Korean RVO study.
    Yoon YH; Kim HK; Yoon HS; Kang SW; Kim JG; Park KH; Jo YJ; Lee JY; Lee DH;
    Jpn J Ophthalmol; 2014 Mar; 58(2):146-54. PubMed ID: 24477666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
    Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Outcomes of Ranibizumab Treatment in French Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion: 24-Month Results from the BOREAL-RVO Study.
    Glacet-Bernard A; Girmens JF; Kodjikian L; Delcourt C; Fajnkuchen F; Creuzot-Garcher C; San Nicolas N; Massin P
    Ophthalmic Res; 2023; 66(1):824-834. PubMed ID: 36972579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).
    Kornhauser T; Schwartz R; Goldstein M; Neudorfer M; Loewenstein A; Barak A
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):835-44. PubMed ID: 26269374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
    Fan C; Wang Y; Ji Q; Zhao B; Xie J
    Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
    Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
    Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
    Campochiaro PA; Sophie R; Pearlman J; Brown DM; Boyer DS; Heier JS; Marcus DM; Feiner L; Patel A;
    Ophthalmology; 2014 Jan; 121(1):209-219. PubMed ID: 24112944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Thapa R; Poudyal G
    Nepal J Ophthalmol; 2013; 5(1):63-8. PubMed ID: 23584649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
    Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
    Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
    Guthoff R; Meigen T; Hennemann K; Schrader W
    Ophthalmologica; 2010; 224(5):319-24. PubMed ID: 20424494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial.
    Campochiaro PA; Hafiz G; Mir TA; Scott AW; Solomon S; Zimmer-Galler I; Sodhi A; Duh E; Ying H; Wenick A; Shah SM; Do DV; Nguyen QD; Kherani S; Sophie R
    Ophthalmology; 2015 Jul; 122(7):1426-37. PubMed ID: 25972260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.
    Kang HM; Chung EJ; Kim YM; Koh HJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.